Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Cytochromes P450
    (7)
  • Others
    (4)
TargetMol | Tags By ResearchField
  • Cardiovascular System
    (4)
  • Metabolism
    (4)
  • Immune System
    (1)
  • Inflammation
    (1)
  • Nervous System
    (1)
Filter
Search Result
Results for "

cyp4a

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    10
    TargetMol | All_Pathways
  • Natural Products
    2
    TargetMol | Natural_Products
  • Antibody Products
    1
    TargetMol | Antibody_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
  • CAY10434
    T37825769917-29-5
    CAY10434 is an active inhibitor of CYP4A hydroxylase with an IC50 value of 8.8 nM in human kidney microsomal test. The maximum contractile value (Emax) of CAY 10434 was 6764 mg in improving the contractile process of angiotensin II.
    • $34
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ε-​Viniferin
    epsilon-Viniferin
    T1121862218-08-0
    ε-Viniferin (epsilon-Viniferin) a dimer of resveratrol, shows the inhibitory effects of epsilon-viniferin on human CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2E1, CYP3A4 and CYP4A activities.
    • $179
    In Stock
    Size
    QTY
  • CAY10462
    CTK8E8405, CAY10462
    T37826502656-68-0
    CAY10462 (CTK8E8405) is an effective and selective inhibitor of the 20-HETE synthase CYP4A11 with an IC50 of 8.8 nM. CAY10462 exhibits nearly 200 times less potent for 1A, 1C, and 3A CYP450 enzymes.
    • $29
    In Stock
    Size
    QTY
  • CYP4A11/CYP4F2-IN-1
    T72501502654-40-2
    CYP4A11/CYP4F2-IN-1 is a cytochrome P450 (CYP) 4A11 and CYP4F2 inhibitor, applicable for research on kidney, cardiovascular, and cerebrovascular diseases.
    • $88
    In Stock
    Size
    QTY
  • CYP4A11/CYP4F2-IN-2
    T861512280834-99-1
    CYP4A11/CYP4F2-IN-2 (compound 15) serves as an orally administered inhibitor targeting CYP4A11/4F2, exhibiting IC50 values of 120 nM and 220 nM, respectively. This compound effectively suppresses 20-HETE production within the rat kidney and shows promise in mitigating the progression of diabetic nephropathy and autosomal dominant polycystic kidney disease [1].
    • $1,820
    10-14 weeks
    Size
    QTY
  • HET0016
    T11556339068-25-6
    HET0016 is a potent and selective 20-HETE synthase inhibitor (IC50s: 17.7 nM, 12.1 nM, and 20.6 nM for recombinant CYP4A1-, CYP4A2-, and CYP4A3-catalyzed 20-HETE synthesis) and a selective CYP450 inhibitor, shown to inhibit angiogenesis and tumor growth.
    • $29
    In Stock
    Size
    QTY
  • TP0472993
    T679162126874-77-7
    CYP4A11/CYP4F2-IN-2 is a potent and orally active dual inhibitor of cytochrome P450 (CYP) 4A11 and CYP4F2, with IC50 values of 140 nM and 40 nM, respectively. Extractable from liver and kidney, CYP4A11/CYP4F2-IN-2 has the potential to treat kidney diseases.
    • $44
    In Stock
    Size
    QTY
  • 20-HETE inhibitor-2
    T2083142992666-48-3
    20-HETE inhibitor-2 is an effective inhibitor of 20-HETE synthesis. It reduces 20-HETE production by blocking CYP4A/CYP4F, exhibiting antihypertensive and renoprotective effects in cardiovascular research.
    • $116
    In Stock
    Size
    QTY
  • 1-Deoxysphingosine (m18:1(14Z))
    1-deoxySO, 14Z-1-Deoxysphingosine (d18:1)
    T852562190487-94-4
    1-Deoxysphingosine (m18:1(14Z)) is an unconventional sphingolipid featuring a (14Z) double bond at the n-4 position, synthesized when serine palmitoyltransferase combines palmitoyl-CoA with alanine, not serine, during sphingolipid production. Unlike typical sphingolipids, it lacks the essential C1-hydroxyl group for standard degradation but undergoes metabolism by cytochrome P450 (CYP) subfamilies CYP4A and CYP4F in MEF cells.
    • $397
    35 days
    Size
    QTY
  • ε-Viniferin (Standard)
    TMSM-061962218-08-0
    ε-Viniferin (Standard) is a reference standard for research and analysis in studies involving ε-Viniferin. ε-​Viniferin (epsilon-Viniferin) a dimer of resveratrol, shows the inhibitory effects of epsilon-viniferin on human CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2E1, CYP3A4 and CYP4A activities.
    • $1,280
    7-10 days
    Size
    QTY